- Investing Ideas
- /
- Taiwanese Healthcare Undervalued over 20% based on DCF
Taiwanese Healthcare Undervalued over 20% based on DCF
Results
9
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
9 companies
Pegavision
Market Cap: NT$24.5b
Manufactures and sells medical devices, and optical and precision instruments in Taiwan.
6491
NT$314.50
7D
-2.2%
1Y
-19.2%
TaiDoc Technology
Market Cap: NT$11.9b
Manufactures and markets medical devices in Taiwan and internationally.
4736
NT$125.00
7D
0.4%
1Y
-19.6%
St.Shine OpticalLtd
Market Cap: NT$8.2b
Manufactures, sells, and trades contact lenses, optical lenses, and related products in Asia, Europe, America, and Taiwan.
1565
NT$163.50
7D
1.2%
1Y
-2.4%
Bioteque
Market Cap: NT$7.7b
Manufactures and sells medical devices in Asia, South America, North America, and internationally.
4107
NT$111.50
7D
-0.4%
1Y
-7.5%
Pacific Hospital Supply
Market Cap: NT$6.6b
Manufactures, processes, and sells medical disposable products and equipment in Taiwan.
4126
NT$90.50
7D
0.2%
1Y
9.4%
WeLeader Biomedical
Market Cap: NT$3.0b
Operates as an agent and distributor of in vitro diagnostic products.
7713
NT$65.60
7D
1.4%
1Y
-5.6%
Wellell
Market Cap: NT$2.3b
Engages in the manufacture, import, export as well as sales of medical supplies worldwide.
4106
NT$22.50
7D
-0.4%
1Y
-12.5%
Level Biotechnology
Market Cap: NT$1.0b
Engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan.
3118
NT$32.15
7D
0.2%
1Y
3.0%
Feng Chi Biotech
Market Cap: NT$292.6m
Provides preimplantation genetic testing, prenatal testing, life science, newborn screening, food/pharmaceutical microbiological testing, and medical translational research services.
6744
NT$19.00
7D
-4.0%
1Y
-5.2%